JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...
JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...
JMP Securities analyst Patrick Walravens maintained a Buy rating on Sprinklr (CXM – Research Report) today and set a price target of $17.00.
In a report released today, David Turkaly from JMP Securities maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...